Stay updated on Nivolumab Plus Ipilimumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Plus Ipilimumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Plus Ipilimumab in Melanoma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Melanoma and MedlinePlus Genetics were added to the page as related topics, providing disease context and a link to genetic resources. This change expands navigation to related information without altering the core study data.
    Difference
    0.1%
    Check dated 2026-07-10T22:50:19.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The revision label on the page changed from v3.6.2 to v3.6.3, indicating a new build behind the interface.
    Difference
    0.0%
    Check dated 2026-07-03T22:09:05.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The page’s revision label was updated from v3.6.0 to v3.6.2. This indicates a backend or UI patch, while the study details and page content remain unchanged.
    Difference
    0.0%
    Check dated 2026-06-26T19:34:35.000Z thumbnail image
  4. Check
    31 days ago
    Change Detected
    Summary
    The page now indicates that recruitment is closed and adds new help/navigation sections such as 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study'. It also standardizes the Intervention/Treatment header and introduces the 'Revision: v3.6.0' tag, replacing the previous formatting.
    Difference
    0.2%
    Check dated 2026-06-12T13:34:17.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    Added a new revision tag: Revision: v3.5.5. The Melanoma topic and related topics, including MedlinePlus Genetics, as well as the older revision tag v3.5.4, were removed.
    Difference
    0.1%
    Check dated 2026-06-05T08:27:01.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    The page adds a Melanoma related topic and a MedlinePlus Genetics link under related topics, extending disease context and accessible resources.
    Difference
    0.1%
    Check dated 2026-05-22T03:56:12.000Z thumbnail image

Stay in the know with updates to Nivolumab Plus Ipilimumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus Ipilimumab in Melanoma Clinical Trial page.